Meinolf Suttorp

Professor Suttorp is board-certified in Pediatrics and Pediatric Hemato-Oncology. He holds a Senior Professorship in Pediatric Hematology/Oncology as the former Head of the Div. of Pediatric Hemato-Oncology & Stem Cell Transplantation at Technical University, Childrens‘ Hospital, in Dresden, Germany. He obtained his academic degrees (Dipl.-Chem.) in Organic Chemistry at the University of Münster and in Human Medicine at the University of Kiel, Germany. His research interests focus on chimerism following allogeneic stem cell transplantation, strategies for optimisation of chronic myeloid leukemia (CML) treatment in children, and the molecular characterization of the chromosomal translocation t(9;22), as well as techniques for detection of minimal residual disease in pediatric CML. In a juvenile rodent animal model, the osseous long-term side effects of tyrosine kinase inhibitor treatment in growing organisms were assessed. Dr. Suttorp initiated academic trials on treatment of pediatric CML (CML-paed I, CML-paed II). He was former chair of the pediatric CML-Working Party of the International BFM (I-BFM) Study Group and in his role as a pediatric hemato-oncologist, he is member of the Advisory Board of the International CML Foundation (iCMLf). He is an active member of multiple scientific societies in the field of Hematology/Oncology (ASH, EBMT, GPOH, I-BFM). He has authored or co-authored numerous articles in books and in international peer-reviewed journals.